Anti-cholinergics for axial symptoms in Parkinson's disease after subthalamic stimulation

Clinical Neurology and Neurosurgery

Volumn 114, Issue 10, 2012, Pages 1308-1311

  Baba, Yasuhiko ^a   Higuchi, Masa Aki ^b   Abe, Hiroshi ^b   Fukuyama, Kouzou ^c   Onozawa, Rieko ^b   Uehara, Yoshinari ^b   Inoue, Tooru ^b   Yamada, Tatsuo ^b  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUKUOKA WAJIRO HOSPITAL   (Japan)

Author keywords

Axial symptoms; Deep brain stimulation; Parkinson's disease; Trihexyphenidyl

Indexed keywords

TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; SCORING SYSTEM; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE;

ACTIVITIES OF DAILY LIVING; AGED; CHOLINERGIC ANTAGONISTS; DEEP BRAIN STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; TRIHEXYPHENIDYL;

EID: 84869082818     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.03.046     Document Type: Article

References (27)

1. P. Krack, A. Batir, N. Van Blercom, S. Chabardes, V. Fraix, and C. Ardouin Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease New England Journal of Medicine 349 2003 1925 1934
2. The Deep-Brain Stimulation for Parkinson's Disease Study Group Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease New England Journal of Medicine 345 2001 956 963
3. K. Ostergaard, N. Sunde, and E. Dupont Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations Movement Disorders 17 2002 693 700
4. G. Kleiner-Fisman, D.N. Fisman, E. Sime, J.A. Saint-Cyr, A.M. Lozano, and A.E. Lang Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease Journal of Neurosurgery 99 2003 489 495
5. W.M. Schüpbach, N. Chastan, M.L. Welter, J.L. Houeto, V. Mesnage, and A.M. Bonnet Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up Journal of Neurology, Neurosurgery and Psychiatry 76 2005 1640 1644
6. C.H. Markham, and S.G. Diamond Long-term follow-up of early dopa treatment in Parkinson's disease Archives of Neurology 19 1986 365 372
7. A.M. Bonnet, Y. Loria, M.H. Saint-Hilaire, F. Lhermitte, and Y. Agid Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 37 1987 1539 1542
8. R.A. Hauser, J.P. Hubble, D.D. Truong, and Istradefylline US-001 Study Group Randomized trial of the adenosine A (2A) receptor antagonist istradefylline in advanced PD Neurology 61 2003 297 303
9. Z. Preston, K. Lee, L. Widdowson, T.C. Freeman, A.K. Dixon, and P.J. Richardson Adenosine receptor expression and function in rat striatal cholinergic interneurons British Journal of Pharmacology 130 2000 886 890
10. R.J. Rodrigues, P.M. Canas, L.V. Lopes, C.R. Oliveira, and R.A. Cunha Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats Neurobiology of Aging 29 2008 1597 1601
11. K. Takakusaki, N. Shimoda, K. Matsuyama, and S. Mori Discharge properties of medullary reticulospinal neurons during postural changes induced by intrapontine injections of carbachol, atropine and serotonin, and their functional linkages to hindlimb motoneurons in cats Experimental Brain Research 99 1994 361 374
12. K. Takakusaki, T. Habaguchi, J. Ohtinata-Sugimoto, K. Saitoh, and T. Sakamoto Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction Neuroscience 119 2003 293 308
13. 1 adenosine antagonists enhance the anticataleptic action of trihexyphenidyl in rats Neuroscience Letters 346 2003 1 4
14. A.E. Lang, and H. Widner Deep brain stimulation for Parkinson's disease: patient selection and evaluation Movement Disorders 17 Suppl. 3 2002 S94 S101
15. S. Fahn, and R.L. Elton Unified Parkinson's disease rating scale S. Fahn, C.D. Marsden, D. Calne, M. Goldstein, Recent developments in Parkinson's disease 1987 MacMillan Health Care Information Florham Park, NJ 153 163
16. K. Grosset, F. Needleman, G. Macphee, and D. Grosset Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table Movement Disorders 19 2004 1370 1374
17. V.E. Kelly, A. Samii, J.C. Slimp, R. Price, R. Goodkin, and A. Shumway-Cook Gait changes in response to subthalamic nucleus stimulation in people with Parkinson disease: a case series report Journal of Neurologic Physical Therapy 30 2006 184 194
18. J. Gan, J. Xie-Brustolin, P. Mertens, G. Polo, H. Klinger, and H. Mollion Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: three years follow-up Journal of Neurology 254 2007 99 106
19. J.S. Perlmutter, and J.W. Mink Deep brain stimulation Annual Review of Neuroscience 29 2006 229 257
20. L. Bekar, W. Libionka, G.F. Tian, Q. Xu, A. Torres, and X. Wang Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor Nature Medicine 14 2008 75 80
21. B.B. Fredholm, J.F. Chen, S.A. Masino, and J.M. Vaugeois Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs Annual Review of Pharmacology and Toxicology 45 2005 385 412
22. S. Fahn Medical treatment of Parkinson's disease Journal of Neurology 245 Suppl. 3 1998 15 24
23. C.W. Olanow, and W.C. Koller An algorithm (decision tree) for the management of Parkinson's disease Neurology 50 1998 1 57
24. J. Brumlik, G. Canter, R. De la Torre, M. Mier, M. Petrovick, and B. Boshes A critical analysis of the effects of trihexyphenidyl (artane) on the components of the parkinsonian syndrome Journal of Nervous and Mental Disease 138 1964 424 431
25. M. Iivainen KR 339 in the treatment of parkinsonian tremor Acta Neurologica Scandinavica 50 1974 469 470
26. R. Cantello, A. Riccio, M. Gilli, M. Delsedime, L. Scarzella, and M. Aguggia Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients Italian Journal of Neurological Sciences 7 1986 139 143
27. U. Freo, G. Pizzolato, M. Dam, C. Ori, and L. Battistin A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials Journal of Neural Transmission 109 2002 857 870